HB

H. Bosch

Botanix Pharmaceuticals Ltd | Non-Executive Director
Dr Bosch has 30 years of experience and industry leadership in pharmaceutical R&D. He served as CSO of iCeutica where he was the principal architect of SoluMatrix drug delivery technology, used in four FDA approved prescription drug products. Earlier in his career, he led the use of nanotechnology in drug development. He served as a co-founder of NanoSystems LLC in 1995 and co-inventor of NanoCrystal Technology. He is also a member of the risk committee.

Company and Role

Company
Title
Tenure
Since
BOT
Botanix Pharmaceuticals Ltd
  • Non-Executive Director
2yrs, 11mthJul 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
Botanix Pharmaceuticals Ltd
20/04/2620,503,369N/A1,666,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
Botanix Pharmaceuticals Ltd
20/04/26
Issued
1,666,667$0.035$58,333Placement
BOT
Botanix Pharmaceuticals Ltd
10/04/26
Issued
1,666,667$0.060$100,000Placement
BOT
Botanix Pharmaceuticals Ltd
02/12/24
Issued
3,000,000$0.350$1,050,000Issue of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Buy
500,000$0.085$42,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Exercise
500,000$0.085$42,500Conversion of securities